News

KRTL Holding Announces KRTL Biotech Facilitates FDA Registration of SIGMACORP as a U.S. Pharmaceutical Manufacturer

A Milestone for KRTL Holding Group, Inc. (OTC: KRTL)

Fostering a Strategic Partnerships to Penetrate Emerging CBD/THC Research Industry in Bolivia

KRTL Biotech, Inc. Announces Leadership Transition and Strategic Partnerships

KRTL Partnered to Bring Cloud and Endpoint Security and AI Powered Telemedicine Solutions

KRTL International Corp. to Bring Singani to US

Cannabis Global and KRTL Announce Exclusive Distribution Agreement for Huella Singani

KRTL and Yuhan to Begin the Development of Products Between Korea and the US

Quantum International Corp. (QUAN) Provides Updates on CannaLootUp and LootUp Apps

David Beling Appointed Strategic Advisor for KRTL Holdings Group Inc

KRTL International Corp. and Cannabis Global Inc. Form Global Strategic Alliance

KRTL INTERNATIONAL AND ICANN VENTURES TO LAUNCH CANNABIS EDUCATION PROGRAM IN KOREA

KRTL BIOTECH AND ENTEXS CORPORATION ACCELERATE ALLIANCE AT MJBIZCON AND IN SOUTH KOREA INITIATIVES

KRTL to Launch Proprietary Mobile Extraction Technology to Disrupt Cannabis Industry

KRTL Holding Group Inc’s Accomplishments and Operational Description

KRTL Holding Group Inc Welcomes Dr. Malcolm A. Leissring as Chief Science Officer of KRTL Biotech

FINRA Approves Name and Ticker Change for KRTL Holding Group, Inc. From QUEENCH, Inc.

Here To Serve Holding Corp. Sells Portion of Its Hemp Farming Project for $500,000

KRTL and PERVASIP ANNOUNCE “ARTIZEN WELLNESS” TARGETING THE $1 TRILLION GLOBAL MARKET

KRTL International Corp. with Artizen Corporation Partner to act as Exclusive Consultants in S Korea